61-56-3
61-56-3
Chemical Structure
Sultiame
- CAS No.: 61-56-3
- Formula:C10H14N2O4S2
- Molecular Weight:290.36
IUPAC Name: 4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
InChIKey: HMHVCUVYZFYAJI-UHFFFAOYSA-N
SMILES: O=S(C1=CC=C(N(CCCC2)S2(=O)=O)C=C1)(N)=O
Biological Activity: Sultiame is a carbonic anhydrase inhibitor, widely used as an antiepileptic agent.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sultiame | 98.89% | Sultiame is a carbonic anhydrase inhibitor, widely used as an antiepileptic agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sultiame (Standard) | ≥98% | Sultiame (Standard) is the analytical standard of Sultiame. This product is intended for research and analytical applications. Sultiame is a carbonic anhydrase inhibitor, widely used as an antiepileptic agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sulthiame-d4 | Sulthiame-d4 is the deuterium labeled Sultiame. Sultiame is a carbonic anhydrase inhibitor, widely used as an antiepileptic agent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
INK4C-IN-2 | 98.35% | INK4C-IN-2 is a p18INK4C inhibitor. NK4C-IN-2 promotes hematopoietic stem cells (HSCs) division by inhibiting INK4C and activating CDK4/6, with an ED50 of 5.21 nM. INK4C-IN-2 shows no cytotoxic to normal 32D cells, HSCs, leukemia cell lines and myeloma cell lines. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
VP-4604 (Standard) | ≥98% | VP-4604 (Standard) is the analytical standard of VP-4604. This product is intended for research and analytical applications. VP-4604 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) agent. VP-4604 exhibits significant microbial growth inhibition toward Staphylococcus aureus (ATCC 43300) with MIC of 4-8 μg/mL. VP-4604 inhibits the growth of methicillin‐resistant Staphylococcus aureus with growth inhibition >95%. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HTS13517 | HTS13517 is a DPP4 inhibitor, with an IC50 of 10.73 μM. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
S-6123 | S-6123 is a potent antimicrobial compound of the oxazolidinone series. S-6123 inhibits ribosomal protein synthesis without inhibiting DNA or RNA synthesis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CRT0083914 | CRT0083914 is a subtype-selective non-carboxylate inhibitor of AKR1C3. CRT0083914 is applicable to the research of colon cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mafenide Acetate (Standard) | ≥98% | Mafenide (Acetate) (Standard) is the analytical standard of Mafenide Acetate (HY-B0614A). This product is intended for research and analytical applications. Mafenide Acetate is a potent sulfonamide antimicrobial agent. Mafenide Acetate exhibits antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa. Mafenide Acetate also exhibits antifungal activity against filamentous fungi (e.g., Lichtheimia and Aspergillus flavus). Mafenide Acetate can be used in the research of skin grafts on burn wounds, post-traumatic invasive fungal infections, and bacterially contaminated wounds. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mafenide propionate | Mafenide propionate is a dual inhibitor of dihydropteroate synthase (Dihydropteroate synthase) and carbonic anhydrase (Carbonic anhydrase). Mafenide propionate disrupts nucleotide biosynthesis by inhibiting the de novo base synthesis pathway, thereby exerting broad-spectrum antibacterial and cytotoxic effects without inducing mutations. Mafenide propionate can be used for wound assessment and promotes the formation of healthy granulation tissue, making it suitable for scenarios such as mesh skin grafting. Mafenide propionate has been widely used in studies on diseases associated with burn wound infections, acute and chronic wounds, blast injuries, open fractures, and necrotizing fasciitis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glipizide impurity 11 | Glipizide impurity 11 is an impurity of Glipizide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
hCAI/II/XII-IN-1 | hCAI/II/XII-IN-1 (compound 7) is a human carbonic anhydrase hCAI/II/XII inhibitor, with Ki values of 78.5, 9.1, 605, 7.7 and 3.7 nM. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
